Project Grant R01NS134632
Award Date
9/1/24
Completion Date
6/30/28
Dollars Obligated
$742K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
San Diego, CA 92121, USA
Similar Awards
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $646,104 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the San Diego Biomedical Research Institute, a non-profit research organization. The grant supports research to investigate how neuroinflammation mediated by the interleukin-13 receptor signaling pathway may contribute to the selective loss of dopaminergic neurons in Parkinson's disease. The...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $173,140 to The Regents of the University of California, San Francisco (UCSF) to elucidate the role of neural activity in the degeneration of midbrain dopamine neurons in Parkinson's disease. The research project aims to chronically manipulate the activity and...
This $682,493 federal Project Grant award, issued by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research at the Albert Einstein College of Medicine to investigate the role of aberrant histone acetylation in the pathogenesis of Parkinson's disease and related synucleinopathies. The research aims to elucidate the functional significance of histone...
This $406,260 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program will fund research to understand the spread of alpha-synuclein aggregates, which is believed to be a key mechanism underlying the onset and progression of Parkinson's disease (PD) and related dementias. The research aims to use fluorescence lifetime imaging microscopy...
This $670,600 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support research to better understand the role of microglia, a type of immune cell in the brain, in the onset and progression of Parkinson's disease (PD). The research aims to determine whether increased density of the colony stimulating factor 1 receptor (CSF1R), a marker of...
This federal Project Grant award of $669,115 from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 "Extramural Research Programs in the Neurosciences and Neurological Disorders" supports research to understand the striatal trans-synaptic signaling mechanisms underlying Parkinson's disease pathology. The primary awardee, Texas A&M University System Health Science Center, will utilize advanced microscopy, electrophysiology, optogenetics, and...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will provide $655,329 to Albert Einstein College of Medicine to investigate the role of the GPNMB gene in the pathogenesis of Parkinson's disease, Lewy body dementia, and related synucleinopathies. The 5-year research project aims to identify causal genetic variants that regulate GPNMB...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $799,127 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to Baylor College of Medicine to develop oligomeric alpha-synuclein targeted nano scavengers as a theranostic (diagnostic and therapeutic) approach for Parkinson's disease. The project aims to fully establish the preclinical potential of this nano scavenger concept across the prodromal, early, and...
This $227,205 federal Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research examining the effects of the Parkinson's disease-associated protein LRRK2 on lysosomal function and inflammatory activity in human microglia. The 5-year project, conducted by Northwestern University, aims to investigate how LRRK2 and the GBA1 gene interact to...
This federal Project Grant award, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to determine the molecular mechanism by which the gut microbiome initiates alpha-synuclein aggregation, a key driver of Parkinson's disease pathology. The total award amount is $501,059, with a project period from September 1, 2024 to August 31, 2029. The...